Nano-X Imaging (NNOX) announced that it will showcase its Nanox.ARC digital tomosynthesis system live in Europe for the first time and present new AI solutions in development at the European Congress of Radiology, ECR, taking place March 4-8, 2026 in Vienna, Austria. “Presenting the Nanox.ARC live in Europe for the first time, a year after receiving CE Mark certification, represents a significant milestone in our European market expansion,” said Erez Meltzer, CEO and Acting Chairman of Nanox. “European healthcare systems need advanced imaging solutions that can operate beyond major medical centers, and that is exactly what the Nanox.ARC was designed to do. At ECR 2026, we will highlight new AI capabilities and clinical evidence demonstrating the performance of the capabilities of the Nanox.ARC in lung cancer screening, as shown in clinical studies. We remain focused on making high-quality imaging more affordable, more accessible and available at scale with our end-to-end imaging solutions.”
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on NNOX:
- Nano-X Imaging Secures FDA 510(k) Clearance for TAP2D Image Enhancement on Nanox.ARC Systems
- Nano-X Imaging receives FDA 510k clearance for TAP2D
- Nano-X Imaging announces new collaboration with Adriamed d.o.o. Beograd
- Nano-X Imaging Shareholders Approve All Proposals at 2025 Annual Meeting
- Nano-X Imaging Adjourns Annual Shareholders’ Meeting by One Day for Lack of Quorum
